603858 步长制药
已收盘 04-30 15:00:00
资讯
新帖
简况
步长制药： 上市公司股价受到宏观经济环境、行业政策、市场行情等多重因素影响
证券之星 · 04-30 18:03
步长制药： 上市公司股价受到宏观经济环境、行业政策、市场行情等多重因素影响
步长制药04月30日主力资金流出1130万元 连续3日减仓
自选股智能写手 · 04-30 15:19
步长制药04月30日主力资金流出1130万元 连续3日减仓
步长制药2023年营收132.45亿净利3.19亿 总裁赵超薪酬243.96万
挖贝网 · 04-28
步长制药2023年营收132.45亿净利3.19亿 总裁赵超薪酬243.96万
步长制药：拟对外投资设立的子公司北京博源润步医药研发有限公司完成工商注册，注册资本2500万元
金融界 · 04-26
步长制药：拟对外投资设立的子公司北京博源润步医药研发有限公司完成工商注册，注册资本2500万元
步长制药2023年营收132.5亿元，同比减少11.4%丨年报速递
地产k线 · 04-26
步长制药2023年营收132.5亿元，同比减少11.4%丨年报速递
步长制药最新公告：控股子公司药品临床试验申请获受理
证券之星 · 04-26
步长制药最新公告：控股子公司药品临床试验申请获受理
独家产品被“定点砍价”，步长制药却在大量囤积药材
健识局 · 04-26
独家产品被“定点砍价”，步长制药却在大量囤积药材
步长制药(603858)3月31日股东户数7.15万户，较上期减少2.98%
证券之星 · 04-26
步长制药(603858)3月31日股东户数7.15万户，较上期减少2.98%
千金藤素概念盘中跳水，步长制药跌9.77%
自选股智能写手 · 04-26
千金藤素概念盘中跳水，步长制药跌9.77%
步长制药创2月新低 子公司产品使用范围受限
智选洞察 · 04-26
步长制药创2月新低 子公司产品使用范围受限
图解步长制药一季报：第一季度单季净利润同比减74.96%
证券之星 · 04-26
图解步长制药一季报：第一季度单季净利润同比减74.96%
图解步长制药年报：第四季度单季净利润同比增78.32%
证券之星 · 04-26
图解步长制药年报：第四季度单季净利润同比增78.32%
V观财报｜步长制药一季度净利降超七成
中新经纬 · 04-25
V观财报｜步长制药一季度净利降超七成
步长制药：拟购买理财产品 投资金额为最高额度不超过人民币15亿元
每日经济新闻 · 04-25
步长制药：拟购买理财产品 投资金额为最高额度不超过人民币15亿元
步长制药最新公告：2023年净利润3.19亿元 同比扭亏为盈
证券之星 · 04-25
步长制药最新公告：2023年净利润3.19亿元 同比扭亏为盈
步长制药(603858.SH)发布一季度业绩，净利润1.14亿元，同比下降74.96%
智通财经 · 04-25
步长制药(603858.SH)发布一季度业绩，净利润1.14亿元，同比下降74.96%
步长制药(603858.SH)发布2023年度业绩，净利润3.19亿元，扭亏为盈
智通财经 · 04-25
步长制药(603858.SH)发布2023年度业绩，净利润3.19亿元，扭亏为盈
步长制药最新公告：一季度净利润同比下降74.96%
证券之星 · 04-25
步长制药最新公告：一季度净利润同比下降74.96%
步长制药：一季度净利润同比下降74.96%
证券之星 · 04-25
步长制药：一季度净利润同比下降74.96%
步长制药在北京成立研发公司 注册资本2500万
天眼查 · 04-23
步长制药在北京成立研发公司 注册资本2500万
加载更多
公司概况
公司名称：
山东步长制药股份有限公司
所属行业：
医药制造业
上市日期：
2016-11-18
主营业务：
山东步长制药股份有限公司主要从事中成药的研发、生产和销售。主要产品涉及心脑血管疾病中成药领域，同时也覆盖妇科用药等其他领域，目前，公司正向生物制药、疫苗等医药高科技领域进军与扩张。
发行价格：
55.88
{"stockData":{"symbol":"603858","market":"SH","secType":"STK","nameCN":"步长制药","latestPrice":16.43,"timestamp":1714460400000,"preClose":16.41,"halted":0,"volume":7600611,"delay":0,"floatShares":1106000000,"shares":1106000000,"eps":-0.0202,"marketStatus":"已收盘","marketStatusCode":5,"change":0.02,"latestTime":"04-30 15:00:00","open":16.33,"high":16.6,"low":16.23,"amount":125000000,"amplitude":0.0225,"askPrice":16.44,"askSize":30,"bidPrice":16.43,"bidSize":194,"shortable":0,"etf":0,"ttmEps":-0.0202,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714959000000},"adr":0,"adjPreClose":16.41,"symbolType":"stock","openAndCloseTimeList":[[1714440600000,1714447800000],[1714453200000,1714460400000]],"highLimit":18.05,"lowLimit":14.77,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1106042645,"pbRate":1.57,"roa":"--","roe":"0.98%","epsLYR":0.2884,"committee":0.168831,"marketValue":18172000000,"floatMarketCap":18172000000,"peRate":-813.366368,"changeRate":0.0012,"turnoverRate":0.0069,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-05-06。"},"requestUrl":"/m/hq/s/603858","defaultTab":"news","newsList":[{"id":"2431313872","title":"步长制药：\n上市公司股价受到宏观经济环境、行业政策、市场行情等多重因素影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2431313872","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431313872?lang=zh_cn&edition=full","pubTime":"2024-04-30 18:03","pubTimestamp":1714471425,"startTime":"0","endTime":"0","summary":"根据公司的测算及外部审计、评估结果，拟对通化谷红制药有限公司及吉林天成制药有限公司涉及的商誉减值准备进行计提。基于湖南众测生物科技有限公司目前的经营状况以及对未来经营情况的分析预测，公司财务部门对其商誉进行减值测试与拟计提。上市公司股价受到宏观经济环境、行业政策、市场行情等多重因素影响。公司一直以来十分重视维护投资者的利益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000042403.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431361198","title":"步长制药04月30日主力资金流出1130万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2431361198","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431361198?lang=zh_cn&edition=full","pubTime":"2024-04-30 15:19","pubTimestamp":1714461557,"startTime":"0","endTime":"0","summary":"04月30日, 步长制药股价涨0.12%，报收16.43元，成交金额1.25亿元，换手率0.69%，振幅2.25%，量比0.63。步长制药今日主力资金净流出1130万元，连续3日净流出，上一交易日主力净流出1282万元，今日环比减少11.86%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为57.14%，平均跌幅为1.29%。该股近5个交易日下跌3.52%，主力资金累计净流出3359万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出6454万元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301537448b653d0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301537448b653d0d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430513704","title":"步长制药2023年营收132.45亿净利3.19亿 总裁赵超薪酬243.96万","url":"https://stock-news.laohu8.com/highlight/detail?id=2430513704","media":"挖贝网","top":-1,"share":"https://www.laohu8.com/m/news/2430513704?lang=zh_cn&edition=full","pubTime":"2024-04-28 11:31","pubTimestamp":1714275075,"startTime":"0","endTime":"0","summary":"挖贝网4月28日，步长制药近日发布2023年年度报告，报告期内公司实现营业收入13,245,133,303.78元，同比下滑11.41%；归属于上市公司股东的净利润318,973,324.80元，同比扭亏为盈。报告期内经营活动产生的现金流量净额为-195,605,226.23元，归属于上市公司股东的净资产11,616,993,595.29元。公告显示，报告期内董事、监事、高级管理人员报酬合计1,521.13万元。挖贝网资料显示，步长制药主要从事中成药的研发、生产和销售，同时也在化药、生物药及疫苗等领域进军与扩张。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042811330187b94dc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042811330187b94dc1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430920479","title":"步长制药：拟对外投资设立的子公司北京博源润步医药研发有限公司完成工商注册，注册资本2500万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430920479","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2430920479?lang=zh_cn&edition=full","pubTime":"2024-04-26 23:23","pubTimestamp":1714144994,"startTime":"0","endTime":"0","summary":"4月26日消息， 步长制药 公告，其拟对外投资设立的子公司北京博源润步医药研发有限公司已完成工商登记注册手续，并取得北京经济技术开发区市场监督管理局核发的营业执照。该公司为有限责任公司（法人独资），法定代表人为杨春，注册资本为2500万元，成立日期为2024年04月19日，经营范围包括医学研究和试验发展、 技术服务 、技术开发、技术咨询、技术交流、技术转让、技术推广等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404262330338b57c98b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404262330338b57c98b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430209984","title":"步长制药2023年营收132.5亿元，同比减少11.4%丨年报速递","url":"https://stock-news.laohu8.com/highlight/detail?id=2430209984","media":"地产k线","top":-1,"share":"https://www.laohu8.com/m/news/2430209984?lang=zh_cn&edition=full","pubTime":"2024-04-26 22:47","pubTimestamp":1714142856,"startTime":"0","endTime":"0","summary":"瑞财经 李兰4月25日，步长制药(603858.SH)发布2023年年度报告。2023年度，步长制药实现营业收入132.45亿元，较上年同期减少11.41%，归属于上市公司股东的净利润3.19亿元。在心脑血管用药领域，步长制药已成功开发、培育了脑心通胶囊、稳心颗粒、丹红注射液三个品种，其2023年度合计销售收入达到74.28亿元。相关公司：步长制药sh603858","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042622493487b42970&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042622493487b42970&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430659272","title":"步长制药最新公告：控股子公司药品临床试验申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2430659272","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430659272?lang=zh_cn&edition=full","pubTime":"2024-04-26 21:20","pubTimestamp":1714137643,"startTime":"0","endTime":"0","summary":"步长制药公告，近日公司控股子公司四川泸州步长生物制药有限公司在研品种“BC008-1A注射液”新增适应症的临床试验申请获得国家药监局受理，拟开展适应症为胶质母细胞瘤及非小细胞肺癌、食管癌等晚期实体瘤。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600053950.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430084272","title":"独家产品被“定点砍价”，步长制药却在大量囤积药材","url":"https://stock-news.laohu8.com/highlight/detail?id=2430084272","media":"健识局","top":-1,"share":"https://www.laohu8.com/m/news/2430084272?lang=zh_cn&edition=full","pubTime":"2024-04-26 21:11","pubTimestamp":1714137112,"startTime":"0","endTime":"0","summary":"4月26日，步长制药开盘即大跌超9%，几乎跌停。即便不考虑高额商誉的减值，步长制药2023年与2022年的营收与净利润水平也大大不如前几年。步长制药将2023年的业绩波动归结于：支柱产品销售量的下降与销售结构的改变。国家约谈企业自行降价成为当下控费的新手段。这家公司是步长制药的孙公司，可能提供一些新药研发上的支持。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042621132587b3dec8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042621132587b3dec8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430470228","title":"步长制药(603858)3月31日股东户数7.15万户，较上期减少2.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430470228","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430470228?lang=zh_cn&edition=full","pubTime":"2024-04-26 17:11","pubTimestamp":1714122680,"startTime":"0","endTime":"0","summary":"证券之星消息，近日步长制药披露，截至2024年3月31日公司股东户数为7.15万户，较12月31日减少2197.0户，减幅为2.98%。在中药行业个股中，步长制药股东户数高于行业平均水平，截至3月31日，中药行业平均股东户数为5.19万户。从股价来看，2023年12月31日至2024年3月31日，步长制药区间跌幅为1.59%，在此期间股东户数减少2197.0户，减幅为2.98%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261720188b568a79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261720188b568a79&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430776293","title":"千金藤素概念盘中跳水，步长制药跌9.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430776293","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430776293?lang=zh_cn&edition=full","pubTime":"2024-04-26 09:42","pubTimestamp":1714095766,"startTime":"0","endTime":"0","summary":"04月26日，千金藤素概念盘中跳水，截至09点42分，千金藤素概念整体指数下跌1.09%，报782.600点。从个股上来看，该概念的成分股中，步长制药跌9.77%，理邦仪器、优宁维、阿拉丁跌幅居前。从资金上来看，截止发稿，千金藤素概念主力净流入为-2170.83万，其中方盛制药受到资金热捧，主力净流入112.57万；拉长时间线来看，该板块近20日主力资金净流入-4.74亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240426094246861e9422&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240426094246861e9422&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430707293","title":"步长制药创2月新低 子公司产品使用范围受限","url":"https://stock-news.laohu8.com/highlight/detail?id=2430707293","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2430707293?lang=zh_cn&edition=full","pubTime":"2024-04-26 09:30","pubTimestamp":1714095001,"startTime":"0","endTime":"0","summary":"步长制药表示，主要是本报告期销售规模的减少及产品销售结构变化的影响。步长制药解释，公司全资子公司通化谷红制药产品谷红注射液、控股子公司吉林天成制药产品复方曲肽注射液、复方脑肽节苷脂注射液于2022年底前已陆续调出各省级医保目录，且2023年初被部分省份纳入“省级重点监控合理用药药品目录”，产品的使用范围受到限制等因素，对公司业绩产生持续不利影响。主营业务及业绩步长制药公司主营业务为中成药的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260935557923a7de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260935557923a7de&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430237816","title":"图解步长制药一季报：第一季度单季净利润同比减74.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430237816","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430237816?lang=zh_cn&edition=full","pubTime":"2024-04-26 01:44","pubTimestamp":1714067085,"startTime":"0","endTime":"0","summary":"证券之星消息，步长制药2024年一季报显示，公司主营收入26.41亿元，同比下降24.88%；归母净利润1.14亿元，同比下降74.96%；扣非净利润1.01亿元，同比下降73.25%；负债率46.87%，投资收益-212.22万元，财务费用2775.08万元，毛利率58.66%。财报数据概要请见下图:以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260146578b53e4da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260146578b53e4da&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430523906","title":"图解步长制药年报：第四季度单季净利润同比增78.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430523906","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430523906?lang=zh_cn&edition=full","pubTime":"2024-04-26 00:31","pubTimestamp":1714062715,"startTime":"0","endTime":"0","summary":"证券之星消息，步长制药2023年年报显示，公司主营收入132.45亿元，同比下降11.41%；归母净利润3.19亿元，同比上升120.85%；扣非净利润2.92亿元，同比上升118.21%；其中2023年第四季度，公司单季度主营收入32.62亿元，同比下降10.55%；单季度归母净利润-6.06亿元，同比上升78.32%；单季度扣非净利润-5.09亿元，同比上升81.01%；负债率45.55%，投资收益2129.25万元，财务费用9166.31万元，毛利率68.15%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042600325787affdb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042600325787affdb5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430281879","title":"V观财报｜步长制药一季度净利降超七成","url":"https://stock-news.laohu8.com/highlight/detail?id=2430281879","media":"中新经纬","top":-1,"share":"https://www.laohu8.com/m/news/2430281879?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:56","pubTimestamp":1714053400,"startTime":"0","endTime":"0","summary":"步长制药2024年第一季度实现营业收入26.41亿元，同比下降24.88%；净利润1.14亿元，同比下降74.96%。步长制药表示，主要是本报告期销售规模的减少及产品销售结构变化的影响。步长制药同日披露的2023年年报显示，报告期公司营业收入132.45亿元，同比下降11.41%；归属于上市公司股东的净利润3.19亿元，同比增长120.85%，扭亏为盈。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521581287af804d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521581287af804d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430153236","title":"步长制药：拟购买理财产品 投资金额为最高额度不超过人民币15亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430153236","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2430153236?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:52","pubTimestamp":1714053175,"startTime":"0","endTime":"0","summary":"步长制药（SH 603858，收盘价：17.09元）4月25日晚间发布公告称，公司于2024年4月25日召开第四届董事会第五十三次（年度）会议，审议通过了《关于使用自有资金购买理财产品的议案》。投资金额为最高额度不超过人民币15亿元，在上述额度内，资金可以滚动使用。2023年1至12月份，步长制药的营业收入构成为：医药行业占比99.87%。步长制药的总经理是赵超，男，57岁，学历背景为博士。截至发稿，步长制药市值为189亿元。文章来源：每日经济新闻原标题：步长制药：拟购买理财产品，投资金额为最高额度不超过人民币15亿元","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260001258b53a3d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260001258b53a3d4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430400463","title":"步长制药最新公告：2023年净利润3.19亿元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2430400463","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430400463?lang=zh_cn&edition=full","pubTime":"2024-04-25 20:50","pubTimestamp":1714049445,"startTime":"0","endTime":"0","summary":"步长制药发布2023年年度报告，报告期公司营业收入132.45亿元，同比下降11.41%；归属于上市公司股东的净利润3.19亿元，同比扭亏为盈。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500043862.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430404838","title":"步长制药(603858.SH)发布一季度业绩，净利润1.14亿元，同比下降74.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430404838","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430404838?lang=zh_cn&edition=full","pubTime":"2024-04-25 20:02","pubTimestamp":1714046531,"startTime":"0","endTime":"0","summary":"智通财经APP讯，步长制药(603858.SH)发布2024年第一季度报告，公司营业收入26.41亿元，同比下降24.88%;归属于上市公司股东的净利润1.14亿元，同比下降74.96%;归属于上市公司股东的扣除非经常性损益的净利润1.01亿元，同比下降73.25%;基本每股收益0.1035元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1110410.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430740149","title":"步长制药(603858.SH)发布2023年度业绩，净利润3.19亿元，扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2430740149","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430740149?lang=zh_cn&edition=full","pubTime":"2024-04-25 19:57","pubTimestamp":1714046278,"startTime":"0","endTime":"0","summary":"智通财经APP讯，步长制药(603858.SH)发布2023年年度报告，公司营业收入132.45亿元，同比下降11.41%;归属于上市公司股东的净利润3.19亿元，扭亏为盈;归属于上市公司股东的扣除非经常性损益的净利润2.92亿元，扭亏为盈;基本每股收益0.2884元/股。拟向全体股东每10股派发现金红利1.26元(含税)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1110399.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430405203","title":"步长制药最新公告：一季度净利润同比下降74.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430405203","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430405203?lang=zh_cn&edition=full","pubTime":"2024-04-25 19:20","pubTimestamp":1714044036,"startTime":"0","endTime":"0","summary":"步长制药发布2024年第一季度报告，实现营业收入26.41亿元，同比下降24.88%；归属于上市公司股东的净利润1.14亿元，同比下降74.96%。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500040314.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430035409","title":"步长制药：一季度净利润同比下降74.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430035409","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430035409?lang=zh_cn&edition=full","pubTime":"2024-04-25 19:20","pubTimestamp":1714044036,"startTime":"0","endTime":"0","summary":"步长制药发布2024年第一季度报告，实现营业收入26.41亿元，同比下降24.88%；归属于上市公司股东的净利润1.14亿元，同比下降74.96%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251922268b52d507&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251922268b52d507&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429158674","title":"步长制药在北京成立研发公司 注册资本2500万","url":"https://stock-news.laohu8.com/highlight/detail?id=2429158674","media":"天眼查","top":-1,"share":"https://www.laohu8.com/m/news/2429158674?lang=zh_cn&edition=full","pubTime":"2024-04-23 13:36","pubTimestamp":1713850589,"startTime":"0","endTime":"0","summary":"（原标题：步长制药在北京成立研发公司 注册资本2500万）天眼查App显示，近日，北京博源润步医药研发有限公司成立，法定代表人为杨春，注册资本2500万人民币，经营范围包括医学研究和试验发展，技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广。股权全景穿透图显示，该公司由四川泸州步长生物制药有限公司全资持股，后者由步长制药（603858）、四川天润元企业管理有限公司等共同持股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042313410587a46677&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042313410587a46677&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2016-11-18","address":"山东省菏泽市牡丹区中华西路369号","stockEarnings":[{"period":"1week","weight":-0.0352},{"period":"1month","weight":-0.0185},{"period":"3month","weight":0.0874},{"period":"6month","weight":-0.0414},{"period":"1year","weight":-0.1979},{"period":"ytd","weight":-0.0341}],"companyName":"山东步长制药股份有限公司","boardCode":"AI0027","perCapita":"15468股","boardName":"医药制造业","registeredCapital":"110604万元","compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":0.0209},{"period":"3month","weight":0.1134},{"period":"6month","weight":0.0317},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":0.0437}],"survey":" 山东步长制药股份有限公司主要从事中成药的研发、生产和销售。主要产品涉及心脑血管疾病中成药领域，同时也覆盖妇科用药等其他领域，目前，公司正向生物制药、疫苗等医药高科技领域进军与扩张。","serverTime":1714718385241,"listedPrice":55.88,"stockholders":"71503人(较上一季度减少2.98%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"步长制药(603858)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供步长制药(603858)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"步长制药,603858,步长制药股票,步长制药股票老虎,步长制药股票老虎国际,步长制药行情,步长制药股票行情,步长制药股价,步长制药股市,步长制药股票价格,步长制药股票交易,步长制药股票购买,步长制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"步长制药(603858)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供步长制药(603858)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}